PL3565551T3 - Sposoby leczenia zakażeń bakteryjnych połączeniem waborbaktamu i meropenemu - Google Patents

Sposoby leczenia zakażeń bakteryjnych połączeniem waborbaktamu i meropenemu

Info

Publication number
PL3565551T3
PL3565551T3 PL18735813.0T PL18735813T PL3565551T3 PL 3565551 T3 PL3565551 T3 PL 3565551T3 PL 18735813 T PL18735813 T PL 18735813T PL 3565551 T3 PL3565551 T3 PL 3565551T3
Authority
PL
Poland
Prior art keywords
vaborbactam
meropenem
methods
combination
bacterial infections
Prior art date
Application number
PL18735813.0T
Other languages
English (en)
Polish (pl)
Inventor
Jeffrey S. Loutit
Michael N. Dudley
Elizabeth E. Morgan
Karen FUSARO
David C. Griffith
Olga Lomovskaya
Original Assignee
Melinta Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62791302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3565551(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Therapeutics, Inc. filed Critical Melinta Therapeutics, Inc.
Publication of PL3565551T3 publication Critical patent/PL3565551T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL18735813.0T 2017-01-09 2018-01-08 Sposoby leczenia zakażeń bakteryjnych połączeniem waborbaktamu i meropenemu PL3565551T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762444238P 2017-01-09 2017-01-09
US201762513936P 2017-06-01 2017-06-01
PCT/US2018/012839 WO2018129479A1 (en) 2017-01-09 2018-01-08 Methods of treating bacterial infections

Publications (1)

Publication Number Publication Date
PL3565551T3 true PL3565551T3 (pl) 2024-09-23

Family

ID=62791302

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18735813.0T PL3565551T3 (pl) 2017-01-09 2018-01-08 Sposoby leczenia zakażeń bakteryjnych połączeniem waborbaktamu i meropenemu

Country Status (21)

Country Link
US (1) US12478606B2 (enExample)
EP (2) EP4212157A1 (enExample)
JP (2) JP7436206B2 (enExample)
KR (2) KR102768209B1 (enExample)
CN (1) CN110402139A (enExample)
AU (1) AU2018205327B2 (enExample)
BR (1) BR112019014089A2 (enExample)
CA (1) CA3048650A1 (enExample)
CL (2) CL2019001918A1 (enExample)
CO (1) CO2019008575A2 (enExample)
DK (1) DK3565551T3 (enExample)
ES (1) ES2979266T3 (enExample)
FI (1) FI3565551T3 (enExample)
HU (1) HUE066805T2 (enExample)
MX (2) MX390529B (enExample)
NZ (1) NZ755141A (enExample)
PH (1) PH12019501606A1 (enExample)
PL (1) PL3565551T3 (enExample)
PT (1) PT3565551T (enExample)
SG (1) SG11201906226YA (enExample)
WO (1) WO2018129479A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12478606B2 (en) 2017-01-09 2025-11-25 Melinta Subsidiary Corp. Methods of treating bacterial infections
AU2018345317B2 (en) * 2017-10-03 2024-10-24 Melinta Therapeutics, Inc. Methods of treating bacterial infections
WO2022026993A1 (en) * 2020-07-27 2022-02-03 Northwestern University Antimicrobial choice algorithm for urinary tract infections
CN117940127A (zh) * 2022-07-05 2024-04-26 塞戈瑞·弗拉基米罗维奇·西多连科 治疗多种耐药细菌感染的制剂
WO2024018372A2 (en) * 2022-07-20 2024-01-25 Sri Sathya Sai Institute Of Higher Learning A machine learning platform for predicting uropathogens and their resistance for prescribing suitable urinary infection therapy
JP2026517813A (ja) * 2023-05-02 2026-06-02 シプラ・リミテッド 医薬配合剤及び抗菌剤を含むその組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
FR2936951B1 (fr) 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
RU2599791C2 (ru) 2010-08-10 2016-10-20 Ремпекс Фармасьютикэлз, Инч. Циклические бороновые кислотно-эфирные производные и их использование в терапии
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
CN105393011A (zh) * 2013-05-15 2016-03-09 舍弗勒技术股份两合公司 减少阻力的离合器板
WO2016172208A1 (en) 2015-04-24 2016-10-27 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
US9949995B2 (en) 2015-09-04 2018-04-24 Case Western Reserve University Compositions and methods of treating of bacterial infections with β-lactamase inhibitors
US12478606B2 (en) 2017-01-09 2025-11-25 Melinta Subsidiary Corp. Methods of treating bacterial infections

Also Published As

Publication number Publication date
MX2019008281A (es) 2019-12-02
FI3565551T3 (fi) 2024-06-18
KR20240133785A (ko) 2024-09-04
CO2019008575A2 (es) 2019-08-30
EP3565551A1 (en) 2019-11-13
KR102768209B1 (ko) 2025-02-18
US20190336475A1 (en) 2019-11-07
EP3565551B1 (en) 2024-03-20
PH12019501606A1 (en) 2020-06-15
MX2022001704A (es) 2022-03-11
WO2018129479A1 (en) 2018-07-12
SG11201906226YA (en) 2019-08-27
CL2020001886A1 (es) 2020-12-18
CN110402139A (zh) 2019-11-01
JP2023012538A (ja) 2023-01-25
EP4212157A1 (en) 2023-07-19
US12478606B2 (en) 2025-11-25
KR20190104385A (ko) 2019-09-09
CL2019001918A1 (es) 2020-02-14
EP3565551A4 (en) 2020-09-23
ES2979266T3 (es) 2024-09-25
PT3565551T (pt) 2024-06-14
JP2020504154A (ja) 2020-02-06
BR112019014089A2 (pt) 2020-02-04
JP7436206B2 (ja) 2024-02-21
DK3565551T3 (da) 2024-06-17
AU2018205327B2 (en) 2023-11-30
AU2018205327A1 (en) 2019-07-25
CA3048650A1 (en) 2018-07-12
NZ755141A (en) 2023-01-27
HUE066805T2 (hu) 2024-09-28
MX390529B (es) 2025-03-20

Similar Documents

Publication Publication Date Title
GB2554629B8 (en) Prevention and treatment of microbial infections
HUE066805T2 (hu) Eljárások bakteriális fertõzések vaborbaktám és meropenem kombinációjával történõ kezelésre
EP3316875A4 (en) Methods to diagnose and treat acute respiratory infections
ZA201706348B (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
PT3102218T (pt) Conjunto de dobradiças para uma porta de vidro isolado
DK3630111T3 (en) Compounds and methods for treating bacterial infections
IL267238A (en) The paranase inhibitors and their use
EP3268010A4 (en) Compositions and methods for treating bacterial infection
ZA201804013B (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
SG11202003009QA (en) Methods of treating bacterial infections
GB2558090B (en) Prevention and treatment for microbial infections
EP3606516A4 (en) METHODS OF TREATMENT AND PREVENTION OF INFECTION
EP3664895A4 (en) COMBINATIONS AS WELL AS USES AND TREATMENTS THEREOF
IL253418A0 (en) Nisin-based compounds and their use in the treatment of bacterial infections
EP3102205A4 (en) Treating flavivirus infections with amodiaquine and derivatives thereof
IL271555A (en) Combining its uses and treatments
GB201806976D0 (en) Treating and preventing microbial infections
HK40036490A (en) Methods of treating bacterial infections
HK40026676A (en) Compounds and methods for treating bacterial infections
HK40051024A (en) Methods of treating bacterial infections with minocycline
GB201519483D0 (en) Prevention and treatment of microbial infections
GB201518252D0 (en) Prevention and treatment of microbial infections